论文部分内容阅读
This paper reports a pharmacophylogenetic study of a medicinal plant family,Ranunculaceae,investigating the correlations between their phylogeny,chemical constituents,and pharmaceutical properties.Phytochemical,ethnopharmacological,and pharmacological data were integrated in the context of the systematics and molecular phylogeny of the Ranunculaceae.The chemical components of this family included several representative metabolic groups:benzylisoquinoline alkaloids,ranunculin,triterpenoid saponin,and diterpene alkaloids,among others.Ranunculin and magnoflorine were found to coexist in some genera.The pharmacophylogenetic analysis,integrated with therapeutic information,agreed with the taxonomy proposed previously,in which the family Ranunculaceae was divided into five sub-families:Ranunculoideae,Thalictroideae,Coptidoideae,Hydrastidoideae,and Glaucidioideae.It was plausible to organize the sub-family Ranunculoideae into ten tribes.The chemical constituents and therapeutic efficacy of each taxonomic group were reviewed,revealing the underlying connections between phylogeny,chemical diversity,and clinical use,which should facilitate the conservation and sustainable utilization of the pharmaceutical resources derived from the Ranunculaceae.
This paper reports a pharmacophylogenetic study of a medicinal plant family, Ranunculaceae, investigating the correlations between their phylogeny, chemical constituents, and pharmaceutical properties. Phytochemical, ethnopharmacological, and pharmacological data were integrated in the context of the systematics and molecular phylogeny of the Ranunculaceae. The chemical components of this family included several representative metabolic groups: benzylisoquinoline alkaloids, ranunculin, triterpenoid saponin, and diterpene alkaloids, among others. Ranunculin and magnoflorine were found to coexist in some genera. The pharmacophylogenetic analysis, integrated with therapeutic information, agreed with the taxonomy previously previously, in which the family Ranunculaceae was divided into five sub-families: Ranunculoideae, Thalictroideae, Coptidoideae, Hydrastidoideae, and Glaucidioideae. It was plausible to organize the sub-family Ranunculoideae into ten tribes. The chemical constituents and therapeutic efficacy of ea ch taxonomic group were reviewed, revealing the underlying connections between phylogeny, chemical diversity, and clinical use, which should facilitate the conservation and sustainable utilization of the pharmaceutical resources derived from the Ranunculaceae.